Skip to main content

Table 3 All indicators of the study population (nā€‰=ā€‰86)

From: Reducing the incidence of stroke-associated pneumonia: an evidence-based practice

Variables

Preimplementation group

(nā€‰=ā€‰43)

Postimplementation group

(nā€‰=ā€‰43)

t/U /Ļ‡2

P

SAP

16 (37.2)

6 (14.0)

6.108

0.025*

Indicators of infection

ā€ƒWhite blood cells (109/L)

7.49 (5.51, 9.30)

7.20 (5.51, 8.40)

863.5

0.598

ā€ƒProcalcitonin (ng/ml)

0.083 (0.054, 0.095)

0.054 (0.044, 0.076)

610.5

0.007*

ā€ƒHypersensitive C-reactive protein (mg/L)

8.74 (4.56, 13.60)

5.20 (3.40, 6.70)

636.5

0.013*

Length of stay, days

13 (9, 18)

11 (8, 14)

687.0

0.040*

Total cost, USD

20,351.62 (12,794.51, 32,790.98)

18,139.21 (12,658.4, 32,666.31)

843.0

0.481

NIHSS score

4 (2, 13)

6 (2, 9)

923.0

0.990

Aspiration

16 (37.2)

4 (9.3)

9.382

0.004*

NRS-2002

Ā Ā 

2.549

0.171

ā€ƒĀ ā‰„Ā 3

32 (74.4)

25 (58.1)

Ā Ā 

ā€ƒā€‰<ā€‰3

11 (25.6)

18 (41.9)

Ā Ā 

Serum albumin (g/L)

33.92ā€‰Ā±ā€‰2.90

35.83ā€‰Ā±ā€‰4.20

āˆ’2.459

0.016*

Oral hygiene score

19 (15, 21)

15 (13, 18)

530.5

0.001*

30ā€‰ml water swallowing test

Ā Ā 

6.766

0.149

ā€ƒI

2 (4.7)

10 (23.3)

Ā Ā 

ā€ƒII

15 (34.9)

12 (27.9)

Ā Ā 

ā€ƒIII

16 (37.2)

15 (34.9)

Ā Ā 

ā€ƒIV

6 (14.0)

4 (9.3)

Ā Ā 

ā€ƒV

4 (9.3)

2 (4.7)

Ā Ā 

The degree of dysphagia

Ā Ā 

7.097

0.131

ā€ƒ 0

2 (4.7)

10 (23.3)

Ā Ā 

ā€ƒ 2

15 (34.9)

12 (27.9)

Ā Ā 

ā€ƒ 4

17 (39.5)

16 (37.2)

Ā Ā 

ā€ƒ 5

6 (14.0)

4 (9.3)

Ā Ā 

ā€ƒ 6

3 (7.0)

1 (2.3)

Ā Ā 
  1. *The difference was statistically significant
  2. Results are presented as n (%), meanā€‰Ā±ā€‰standard deviation or median (interquartile range)
  3. SAP stroke-associated pneumonia; NIHSS National Institutes of Health Stroke Scale; NRS nutrition risk screening